Back
NovoCure Vs. Bowman Consulting Group Industry Stock Comparison
Sell
35
NVCR
NovoCure
Last Price:
12.64
Seasonality Move:
12.01%
Sell
31
BWMN
Bowman Consulting Group
Last Price:
32.87
Seasonality Move:
-15.29%
Sell
35
NovoCure (NVCR)
is a Sell
Is NovoCure a Buy, Sell or Hold?
- The current NovoCure [NVCR] share price is $12.23. The Score for NVCR is 35, which is 30% below its historic median score of 50, and infers higher risk than normal.
- NVCR is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
31
Bowman Consulting Group (BWMN)
is a Sell
Is Bowman Consulting Group a Buy, Sell or Hold?
- The current Bowman Consulting Group [BWMN] share price is $32.09. The Score for BWMN is 31, which is 38% below its historic median score of 50, and infers higher risk than normal.
- BWMN is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
NVCR Stock Price Chart
BWMN Stock Price Chart
What is Bowman Consulting Group's stock price today?
-
The Bowman Consulting Group share price today is $32.09
The current trend is relatively stagnant and BWMN is experiencing slight buying pressure.
NVCR Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.69 | Sell |
| Relative Strength Index (14 RSI): | 38.18 | Sell |
| Chaikin Money Flow: | 432127 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (12.35 - 14.63) | Sell |
| Bollinger Bands (100): | (12.91 - 15.45) | Sell |
BWMN Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -1.17 | Sell |
| Relative Strength Index (14 RSI): | 45.71 | Sell |
| Chaikin Money Flow: | 31623 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (30.02 - 36.78) | Sell |
| Bollinger Bands (100): | (30.93 - 36.57) | Sell |
NVCR Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 12.14 | Buy |
| 20-day SMA: | 13.46 | Sell |
| 50-day SMA: | 14.49 | Sell |
| 200-day SMA: | 17.81 | Sell |
| 8-day EMA: | 12.38 | Sell |
| 20-day EMA: | 13.08 | Sell |
| 50-day EMA: | 13.89 | Sell |
| 200-day EMA: | 22.73 | Sell |
BWMN Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 30.88 | Buy |
| 20-day SMA: | 31.87 | Buy |
| 50-day SMA: | 34.54 | Sell |
| 200-day SMA: | 31.57 | Buy |
| 8-day EMA: | 31.38 | Buy |
| 20-day EMA: | 32.33 | Sell |
| 50-day EMA: | 33.49 | Sell |
| 200-day EMA: | 31.56 | Buy |
NovoCure Earnings Growth & NVCR Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.08 per share, an increase next quarter of $0.01 per share, an increase this year of $0.27 per share, and a decrease next year of $0.08 per share.
Bowman Consulting Group Earnings Growth & BWMN Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.37 per share, a decrease next quarter of $0.14 per share, an increase this year of $0.61 per share, and an increase next year of $0.38 per share.
NovoCure Technical Analysis
| Apr 12 | Apr 15 | Apr 16 | Apr 17 | Apr 18 | Apr 19 | Apr 22 | Apr 23 | Apr 24 | Apr 25 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | ||||||||||
| 12 | 15 | 16 | 17 | 18 | 19 | 22 | 23 | 24 | 25 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Bowman Consulting Group Technical Analysis
| Apr 12 | Apr 15 | Apr 16 | Apr 17 | Apr 18 | Apr 19 | Apr 22 | Apr 23 | Apr 24 | Apr 25 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | ||||||||||
| 12 | 15 | 16 | 17 | 18 | 19 | 22 | 23 | 24 | 25 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||